Modulation by LL-37 of the responses of salivary glands to purinergic agonists

Mol Pharmacol. 2006 Jun;69(6):2037-46. doi: 10.1124/mol.105.021444. Epub 2006 Mar 2.

Abstract

The interaction of mice submandibular gland cells with LL-37 (LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES), a cationic peptide with immunomodulatory properties, was investigated. LL-37 at a concentration that did not affect the integrity of the cells increased the uptake of calcium and activated a calcium-insensitive phospholipase A(2) (PLA(2)). The small release of ATP induced by LL-37 could not account for this stimulation because apyrase did not significantly block the response to LL-37. The divalent cation magnesium inhibited the response to LL-37, but this inhibition was probably nonspecific because it also inhibited the in vitro bacteriostatic effect of the peptide. The increase of calcium uptake by LL-37 was not affected by 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazine (KN-62), a rather specific inhibitor of P2X(7) receptors in mice. LL-37 also increased [Ca(2+)](i) in cells from mice invalidated for these receptors. LL-37 had no effect on the response to carbachol. It inhibited the increase of [Ca(2+)](i) and the activation of phospholipase D by ATP. It potentiated the activation of the PLA(2) by the nucleotide. Finally, LL-37 increased the fluidity of the plasma membrane of submandibular gland cells. In conclusion, our results suggest that LL-37 is an autocrine regulator of submandibular gland cells. It does not stimulate mouse P2X(7) receptors but modulates their responses.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / analogs & derivatives
  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / pharmacology
  • Adenosine Triphosphate / metabolism
  • Adenosine Triphosphate / pharmacology
  • Animals
  • Antimicrobial Cationic Peptides / antagonists & inhibitors
  • Antimicrobial Cationic Peptides / metabolism
  • Antimicrobial Cationic Peptides / pharmacology*
  • Calcium / metabolism
  • Cathelicidins
  • Cations, Divalent / pharmacology
  • Cell Membrane / drug effects
  • Enzyme Inhibitors / pharmacology
  • Group IV Phospholipases A2
  • Magnesium / pharmacology
  • Male
  • Membrane Fluidity / drug effects
  • Mice
  • Mice, Inbred C57BL
  • Muscarinic Agonists / metabolism
  • Muscarinic Agonists / pharmacology
  • Phospholipases A / drug effects
  • Purinergic P2 Receptor Agonists*
  • Receptors, Purinergic P2X7
  • Salivary Glands / drug effects
  • Submandibular Gland / drug effects*

Substances

  • Antimicrobial Cationic Peptides
  • Cations, Divalent
  • Enzyme Inhibitors
  • Muscarinic Agonists
  • P2rx7 protein, mouse
  • Purinergic P2 Receptor Agonists
  • Receptors, Purinergic P2X7
  • KN 62
  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
  • Adenosine Triphosphate
  • Phospholipases A
  • Group IV Phospholipases A2
  • Magnesium
  • Calcium
  • Cathelicidins